DarioHealth Analyst Ratings
DarioHealth Analyst Ratings
While ratings are subjective and will change, the latest DarioHealth (DRIO) rating was a maintained with a price target of $5.45 to $4.10. The current price DarioHealth (DRIO) is trading at is $3.15, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 30.16% | Alliance Global Partners | $5.45 → $4.1 | Maintains | Buy |
| 07/25/2023 | 90.48% | Stifel | $9 → $6 | Maintains | Buy |
| 05/12/2023 | 153.97% | Craig-Hallum | $14 → $8 | Maintains | Buy |
| 11/16/2022 | 138.1% | Alliance Global Partners | $9.15 → $7.5 | Maintains | Buy |
| 08/18/2022 | 376.19% | Aegis Capital | $20 → $15 | Maintains | Buy |
| 08/16/2022 | 344.44% | Cowen & Co. | $18 → $14 | Maintains | Outperform |
| 05/16/2022 | 534.92% | Aegis Capital | $23 → $20 | Maintains | Buy |
| 05/16/2022 | 471.43% | Cowen & Co. | $14 → $18 | Maintains | Outperform |
| 05/13/2022 | — | Alliance Global Partners | Upgrades | Neutral → Buy | |
| 01/26/2022 | 693.65% | Aegis Capital | $28 → $25 | Maintains | Buy |
| 08/19/2021 | 788.89% | Aegis Capital | $35 → $28 | Maintains | Buy |
| 04/22/2021 | 884.13% | Cowen & Co. | → $31 | Initiates Coverage On | → Outperform |
| 03/23/2021 | 852.38% | Stifel | → $30 | Initiates Coverage On | → Buy |
| 02/08/2021 | 1011.11% | Aegis Capital | $25 → $35 | Maintains | Buy |
| 08/17/2020 | 693.65% | Aegis Capital | → $25 | Initiates Coverage On | → Buy |
| 06/22/2020 | 217.46% | ThinkEquity | → $10 | Initiates Coverage On | → Buy |
| 05/13/2020 | 153.97% | Craig-Hallum | $7 → $8 | Maintains | Buy |
| 06/06/2019 | -52.38% | Craig-Hallum | → $1.5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/11/2023 | 30.16% | 聯盟全球合作伙伴 | 5.45 美元 → 4.1 美元 | 維護 | 購買 |
| 07/25/2023 | 90.48% | Stifel | 9 美元 → 6 美元 | 維護 | 購買 |
| 05/12/2023 | 153.97% | Craig-Hallum | 14 美元 → 8 美元 | 維護 | 購買 |
| 11/16/2022 | 138.1% | 聯盟全球合作伙伴 | 9.15 美元 → 7.5 美元 | 維護 | 購買 |
| 08/18/2022 | 376.19% | 宙斯盾資本 | 20 美元 → 15 美元 | 維護 | 購買 |
| 08/16/2022 | 344.44% | Cowen & Co. | 18 美元 → 14 美元 | 維護 | 跑贏大盤 |
| 05/16/2022 | 534.92% | 宙斯盾資本 | 23 美元 → 20 美元 | 維護 | 購買 |
| 05/16/2022 | 471.43% | Cowen & Co. | 14 美元 → 18 美元 | 維護 | 跑贏大盤 |
| 05/13/2022 | — | 聯盟全球合作伙伴 | 升級 | 中性 → 買入 | |
| 2022 年 1 月 26 日 | 693.65% | 宙斯盾資本 | 28 美元 → 25 美元 | 維護 | 購買 |
| 08/19/2021 | 788.89% | 宙斯盾資本 | 35 美元 → 28 美元 | 維護 | 購買 |
| 04/22/2021 | 884.13% | Cowen & Co. | → 31 美元 | 啓動覆蓋開啓 | → 跑贏大盤 |
| 2021 年 3 月 23 日 | 852.38% | Stifel | → 30 美元 | 啓動覆蓋開啓 | → 購買 |
| 02/08/2021 | 1011.11% | 宙斯盾資本 | 25 美元 → 35 美元 | 維護 | 購買 |
| 2020 年 8 月 17 日 | 693.65% | 宙斯盾資本 | → 25 美元 | 啓動覆蓋開啓 | → 購買 |
| 2020 年 6 月 22 日 | 217.46% | ThinkEqu | → 10 美元 | 啓動覆蓋開啓 | → 購買 |
| 05/13/2020 | 153.97% | Craig-Hallum | 7 美元 → 8 美元 | 維護 | 購買 |
| 2019 年 6 月 6 日 | -52.38% | Craig-Hallum | → 1.5 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for DarioHealth (DRIO)?
DarioHealth (DRIO) 的目標價格是多少？
The latest price target for DarioHealth (NASDAQ: DRIO) was reported by Alliance Global Partners on August 11, 2023. The analyst firm set a price target for $4.10 expecting DRIO to rise to within 12 months (a possible 30.16% upside). 6 analyst firms have reported ratings in the last year.
Alliance Global Partners於2023年8月11日公佈了DarioHealth（納斯達克股票代碼：DRIO）的最新目標股價。這家分析公司將目標股價定爲4.10美元，預計DRIO將在12個月內升至12個月內（可能上漲30.16％）。去年有6家分析公司公佈了評級。
What is the most recent analyst rating for DarioHealth (DRIO)?
分析師對DarioHealth（DRIO）的最新評級是多少？
The latest analyst rating for DarioHealth (NASDAQ: DRIO) was provided by Alliance Global Partners, and DarioHealth maintained their buy rating.
DarioHealth（納斯達克股票代碼：DRIO）的最新分析師評級由Alliance Global Partners提供，DarioHealth維持買入評級。
When is the next analyst rating going to be posted or updated for DarioHealth (DRIO)?
DarioHealth（DRIO）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DarioHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DarioHealth was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與DarioHealth的高管和客戶交談以及聽取業績電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。DarioHealth 的最後一次評級是在2023年8月11日提交的，因此你應該預計下一個評級將在2024年8月11日左右公佈。
Is the Analyst Rating DarioHealth (DRIO) correct?
分析師的評級 DarioHealth (DRIO) 正確嗎？
While ratings are subjective and will change, the latest DarioHealth (DRIO) rating was a maintained with a price target of $5.45 to $4.10. The current price DarioHealth (DRIO) is trading at is $3.15, which is out of the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的DarioHealth（DRIO）評級維持不變，目標股價爲5.45美元至4.10美元。DarioHealth（DRIO）目前的交易價格爲3.15美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。